B A Teicher, E Frei. Show Affiliations »
Abstract
Mesh： See more » Alkylating Agents/administration & dosageAlkylating Agents/adverse effectsAlkylating Agents/pharmacologyAlkylating Agents/therapeutic useAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useCell HypoxiaCisplatin/administration & dosageCisplatin/adverse effectsCisplatin/pharmacologyCisplatin/therapeutic useDNA DamageDNA Repair/drug effectsDrug CombinationsDrug InteractionsDrug ResistanceFluorocarbons/pharmacologyGlutathione/metabolismGlutathione Transferase/metabolismHumansHydroxyethyl Starch DerivativesIndazoles/pharmacologyMetallothionein/metabolismNeoplasm Proteins/metabolismNeoplasms/drug therapyNeoplasms/metabolismNitroimidazoles/pharmacologyOxygen/pharmacologyRadiation-Sensitizing Agents/pharmacologyTopoisomerase II InhibitorsXanthines/pharmacology
Substances： See more » Alkylating AgentsAntineoplastic AgentsDrug CombinationsFluorocarbonsHydroxyethyl Starch DerivativesIndazolesNeoplasm ProteinsNitroimidazolesRadiation-Sensitizing AgentsTopoisomerase II InhibitorsXanthinesmethylxanthineglucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combinationMetallothioneinGlutathione TransferaseGlutathioneCisplatinOxygenlonidamine
Year: 1991 PMID： 1686721 DOI： 10.1007/978-1-4615-3872-1_13
Source DB: PubMed Journal: Cancer Treat Res ISSN： 0927-3042